No Detail Found!

Efficacy of Levamisole in children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary Care Center-Karachi

Author(s)
Khemchand N Moorani Department of Pediatric Nephrology,National Institute of Child Health,JSMU,Karachi, Pakistan.
Aasia Mohammad Zubair Department of Pediatric Nephrology National Institute of Child Health,JSMU,Karachi, Pakistan.
Nanga Ram Veerwani Department of Pediatric Nephrology,The Kidney Center Postgraduate Training Institute, Karachi Sindh, Pakistan
Harnam Jaichand Hotchandani Department of Pediatric Nephrology,The Kidney Center Postgraduate Training Institute,Karachi Sindh, Pakistan
Abstract
Objectives: To determine the effectiveness of levamisole in maintaining remission of proteinuria in children with frequent relapsing and steroid dependent nephrotic syndrome (FR/SDNS). Methods: This observational study on 81 children with FR /SDNS was carried out from June 2007 - June 2017 at The Kidney Center-Postgraduate Training Institute, Karachi-Pakistan. Levamisole (leva) along with low dose prednisolone on alternate day (AD) was used after induction of remission with daily oral prednisolone in children with FR/ SDNS for 6-36 months. Patients with steroid resistance were excluded. Data was analyzed using descriptive statistics. Results: Eighty-one patients with FR (66) or SD (15) received levamisole treatment. Mean age at diagnosis was 3.72 ±2.33 years. Levamisole was used on AD in 59.25% and daily in 40.74% of cases. Twenty-four could not complete six months and were excluded, 57 patients completed treatment duration of 15.68±9.93 months and 51 post-leva follow-up of 11.70±11.23 months. Mean cumulative prednisolone dose per patient before, on-leva and post-leva was 3389.81±2785.22, 2471.97±2024.98 and 661.37± 905.37 mg respectively. Mean relapse rate per year before leva, on -leva and post -leva was 3.30 ±0.50,0.98± 1.1and 0.79±1.27 respectively. Levamisole was effective in 90% of patients. During post-leva follow up, 76.4% patients, maintained remission, whereas 23.5% behaved as FR/SD and require further immunosuppressive therapy. Conclusions: Levamisole was effective in maintaining remission in 90% while on treatment, whereas it maintained remission after discontinuation in 76.4% cases. Levamisole may be used as first steroid sparing agent before other immunosuppressive therapies in children with FR/SDNS. Further studies are required for optimal duration and dosage schedule.
Publication Details
Page(s) 1193-1198
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 36, Issue: 6, Year: 2020

Request the full text from PASTIC

Keywords
Frequent relapsing, Steroid dependent nephrotic syndrome, Remission of proteinuria
0

Citations

0

Downloads

134

Views